Can Bupropion (Wellbutrin) Cause Cough?
Yes, bupropion can cause cough as a documented adverse effect, occurring in 1-4% of patients in clinical trials, though it is generally mild and does not typically require discontinuation.
Evidence from FDA Drug Labeling
The FDA-approved prescribing information for Wellbutrin explicitly lists "increased cough" as an adverse reaction occurring in controlled trials 1. Specifically:
- In major depressive disorder trials with bupropion sustained-release, increased cough occurred in 1-2% of patients across dosing groups (300-400 mg/day) compared to 1% with placebo 1
- In seasonal affective disorder trials with Wellbutrin XL, cough occurred in 4% of patients on bupropion versus 3% on placebo 1
The cough associated with bupropion appears dose-independent and occurs at similar rates across different formulations.
Clinical Context and Mechanism
While the exact mechanism is not fully elucidated, one case report documented bupropion-associated eosinophilia with non-productive cough that resolved upon drug discontinuation 2. This suggests a potential hypersensitivity mechanism in some cases, though this appears rare.
Importantly, bupropion is actually recommended as a smoking cessation aid in cardiovascular prevention guidelines 3, with cough listed as a possible side effect when used as an oral inhaler for nicotine replacement (not bupropion itself causing airway irritation) 3.
Evaluation and Management Algorithm
Step 1: Establish Temporal Relationship
- Document when cough began relative to bupropion initiation
- Assess cough characteristics (productive vs. non-productive, severity, timing)
Step 2: Rule Out Common Causes
Before attributing cough to bupropion, systematically evaluate for 4, 5:
- Upper airway cough syndrome (postnasal drip)
- Asthma or cough-variant asthma
- Gastroesophageal reflux disease
- ACE inhibitor use (if patient is on concurrent therapy)
- Respiratory infections or exacerbations
Step 3: Assess Severity and Impact
- Mild cough (1-2% incidence): Often does not require intervention
- Moderate to severe cough: Consider diagnostic workup including chest imaging if clinically indicated 4
- Check complete blood count if systemic symptoms present (to evaluate for eosinophilia) 2
Step 4: Management Decision
If cough is mild and tolerable:
- Continue bupropion with monitoring
- Reassess in 2-4 weeks as some medication-related coughs may improve with continued use
If cough is moderate to severe or impacting quality of life:
- Discontinue bupropion and observe for resolution within 1-4 weeks 5, 6
- If cough resolves, this confirms drug-induced etiology
- Consider alternative antidepressants (SSRIs, SNRIs) or smoking cessation agents depending on indication
If bupropion must be continued (compelling psychiatric indication):
- Trial symptomatic cough management with demulcents (simple syrup/linctus) 7
- Consider peripheral antitussives like levodropropizine if available 8, 5
- Avoid central cough suppressants (codeine, dextromethorphan) unless chronic bronchitis is present 8
Critical Caveats
Do not confuse with ACE inhibitor cough: If patient is on both bupropion and an ACE inhibitor, the ACE inhibitor is far more likely the culprit (occurs in up to 10-20% of patients) 5. Discontinue the ACE inhibitor first.
Bupropion-induced cough is NOT a contraindication to use: The incidence is low and comparable to placebo in some trials 1
Monitor for rare hypersensitivity: If cough is accompanied by rash, eosinophilia, or systemic symptoms, consider drug reaction with eosinophilia and systemic symptoms (DRESS) and discontinue immediately 1
Smoking cessation context: When used for smoking cessation, distinguish between medication side effect versus underlying lung pathology from smoking history 9
The key principle is that drug-induced cough diagnosis requires temporal correlation with drug initiation and resolution upon discontinuation within 1-4 weeks 5, 6. Without this confirmation, other etiologies must be pursued systematically.